Sign In to Follow Application
View All Documents & Correspondence

Pharmaceutical Composition Of Lifitegrast And Loteprednol Etabonate

Abstract: The present invention relates to pharmaceutical composition comprising combination of Lifitegrast and Loteprednol etabonate along with one or more pharmaceutically acceptable excipients for the treatment of dry eye disease.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
04 September 2024
Publication Number
52/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

ORBICULAR PHARMACEUTICAL TECHNOLOGIES PVT. LTD
P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090, Telangana

Inventors

1. PATEL, Hiren
Orbicular Pharmaceutical Technologies Pvt. Ltd. P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090, Telangana

Specification

Documents

Application Documents

# Name Date
1 202447066790-REQUEST FOR EXAMINATION (FORM-18) [04-09-2024(online)].pdf 2024-09-04
2 202447066790-POWER OF AUTHORITY [04-09-2024(online)].pdf 2024-09-04
3 202447066790-FORM 18 [04-09-2024(online)].pdf 2024-09-04
4 202447066790-FORM 1 [04-09-2024(online)].pdf 2024-09-04
5 202447066790-DECLARATION OF INVENTORSHIP (FORM 5) [04-09-2024(online)].pdf 2024-09-04
6 202447066790-COMPLETE SPECIFICATION [04-09-2024(online)].pdf 2024-09-04